Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (12)
  • 2025 (31)
  • 2024 (21)
  • 2023 (47)
  • 2022 (65)
  • 2021 (56)
  • 2020 (9)
  • 2019 (6)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4103)
  • Synthetic drugs (1097)
  • Guns/Weapons (1009)
  • OCDETF/Task Force (817)
  • Fake Pills (669)
  • Arrests/Convictions - Major (623)
  • Guilty Plea (540)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (370)
  • Overdose (324)
  • Major Law Enforcement Operation (274)
  • Diversion Division (250)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Money Laundering (207)
  • Gangs (199)
  • Outreach/Drug Prevention (185)
  • Fentanyl Awareness (158)
  • One Pill Can Kill (113)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Fentanyl Free America (24)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Other (11)
  • Campaigns (10)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (226)
  • Counterfeit Pills (25)

Drug Name

  • Oxycodone (50)
  • Fentanyl (46)
  • Opioids (45)
  • Cocaine (14)
  • Hydromorphone (14)
  • Methamphetamine (14)
  • Synthetic Opioids (13)
  • Morphine (8)
  • Benzodiazepines (7)
  • Heroin (4)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • GHB (1)

Field Division

  • Washington, DC (37)
  • St. Louis (33)
  • New York (22)
  • Chicago (19)
  • Miami (16)
  • El Paso (13)
  • Atlanta (12)
  • New England (12)
  • New Jersey (11)
  • Seattle (11)
  • Sede (10)
  • Dallas (9)
  • Houston (7)
  • San Francisco (7)
  • San Diego (6)
  • Louisville (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Omaha (4)
  • Rocky Mountain (4)
  • Phoenix (3)
  • Detroit (1)
  • Philadelphia (1)
Clear All Results
251 Results - Showing 231 to 240
PRESS RELEASE

Justice Department files lawsuit against Creve Coeur pharmacist for Controlled Substances Act violations

ST. LOUIS – In a complaint filed February 23, 2021, by the U.S. Attorney’s Office for the Eastern District of Missouri, the government alleges Elizabeth Dembo unlawfully dispensed controlled substances to patients during her time as the pharmacist-in-charge of Olive Street Pharmacy, LLC. The retail pharmacy is located in the...
PRESS RELEASE

Pharmaceutical Distributor Vistapharm, Inc. Agrees To Pay $325,000 To Resolve Alleged Violations Of The Controlled Substances Act

TAMPA, Fla. - Vistapharm, Inc. has agreed to pay the United States $325,000 to resolve allegations that Vistapharm violated the Controlled Substances Act (CSA) by failing to maintain records required by the CSA. In addition to paying a civil penalty, Vistapharm has agreed to sign separately a Memorandum of Agreement...
PRESS RELEASE

Odessa pharmacy and owner to pay $320,000 in civil penalties

EL PASO, Texas -- Odessa pharmacy Town & Country Drug, Inc. (Town & Country) and its owner, pharmacist Gary Warren, have entered into a civil settlement with the United States that requires them to pay $320,000 in civil penalties to resolve allegations that they violated certain provisions of the Controlled...
PRESS RELEASE

Pharmacy Pays $250,000 to Resolve Controlled Substances Act Violations

ATLANTA – Caduceus USA Medical Pharmacy, LLC (“Caduceus”) has agreed to surrender its DEA registration and pay $250,000 to resolve allegations that it failed to keep proper records of the controlled substances that it purchased, maintained and dispensed in violation of the Controlled Substances Act (CSA). These requirements are designed...
PRESS RELEASE

DA Sini & DEA: Suffolk County Legislator arrested for allegedly offering to illegally supply a prostitute with narcotics in exchange for a sex act

Central Islip, N.Y. – Today, Ray Donovan, Special Agent in Charge of the U.S. Drug Enforcement Administration (DEA), New York Division and Suffolk County District Attorney Timothy D. Sini announced the arrest of a Suffolk County Legislator for allegedly offering to illegally supply narcotics to a prostitute in exchange for...
PRESS RELEASE

Queens Pharmacy Operator charged with Obstruction of Justice for sending powder cocaine to DEA Investigator's home

NEW YORK - Raymond P. Donovan, Special Agent in Charge of the New York Division of the U.S. Drug Enforcement Administration (DEA), Audrey Strauss, Acting United States Attorney for the Southern District of New York (SDNY), and Dermot Shea, the Commissioner of the New York City Police Department (NYPD), announced...
PRESS RELEASE

Ft. Worth Doctors Leave Patients Wasted and Dazed in a Pill Mill Operation; 49 Arrested

FORT WORTH, TX - Forty-nine defendants, including two doctors and five pharmacists, have been charged with participating in an $18 million pill mill scheme, announced by the DEA Dallas Field Division. “Medical professionals hold the public’s trust to provide what is in the best interests of their patients,” said DEA...
PRESS RELEASE

DEA Implements E-commerce Outreach Program to Combat Counterfeit Drug Production

WASHINGTON – The U.S. Drug Enforcement Administration has developed an e-commerce outreach program aimed at reducing the availability of dangerous, often deadly, counterfeit prescription drugs in the United States. This DEA-led initiative focuses on educating online retailers about the sale of pill presses and components used in the production of...
PRESS RELEASE

Indiana doctor surrenders DEA registration for cause

CHICAGO – Special Agent in Charge Robert J. Bell, DEA Chicago Division, announced that on July 17, 2020, Larry R. Brazley, MD, 225 E. 90th Drive, Suite WI, Merrillville, Indiana, surrendered “For Cause” his DEA Practitioner Registration. This investigation revealed that Dr. Brazley was engaged in pre-signing large numbers of...
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...

Paginación

  • Primera página «
  • Anterior
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Current page 24
  • Page 25
  • Page 26
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster